Cherry Biotech

Cherry Biotech markets a technological platform integrating cellular engineering, microfluidics, artificial intelligence and advanced imaging to recreate 3D human models (organs on a chip). Its aim is to anticipate the impact of treatments on the body, particularly for orphan diseases, cancer and bacterial resistance. Its patented CUBIX technology makes it possible to grow complex, vascularized tissue models, offering an ethical and innovative alternative to animal testing, while integrating into current industrial workflows.